Tan Rui-Zhi, Bai Qiu-Xiang, Jia Long-Hao, Wang Yi-Bing, Li Tong, Lin Jing-Yi, Liu Jian, Su Hong-Wei, Kantawong Fahsai, Wang Li
Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China; Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand; Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou 646000, China; Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou 646000, China.
Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China.
Biomed Pharmacother. 2025 Feb;183:117842. doi: 10.1016/j.biopha.2025.117842. Epub 2025 Jan 13.
The interaction between renal intrinsic cells and macrophages plays a crucial role in the onset and progression of kidney diseases. In recent years, epigenetic mechanisms such as DNA methylation, histone modification, and non-coding RNA regulation have become essential windows for understanding these processes. This review focuses on how renal intrinsic cells (including tubular epithelial cells, podocytes, and endothelial cells), renal cancer cells, and mesenchymal stem cells influence the function and polarization status of macrophages through their own epigenetic alterations, and how the epigenetic regulation of macrophages themselves responds to kidney damage, thus participating in renal inflammation, fibrosis, and repair. Moreover, therapeutic studies targeting these epigenetic interaction mechanisms have found that the application of histone deacetylase inhibitors, histone methyltransferase inhibitors, various nanomaterials, and locked nucleic acids against non-coding RNA have positive effects on the treatment of multiple kidney diseases. This review summarizes the latest research advancements in these epigenetic regulatory mechanisms and therapies, providing a theoretical foundation for further elucidating the pathogenesis of kidney diseases and the development of novel therapeutic strategies.
肾固有细胞与巨噬细胞之间的相互作用在肾脏疾病的发生和发展中起着关键作用。近年来,DNA甲基化、组蛋白修饰和非编码RNA调控等表观遗传机制已成为理解这些过程的重要窗口。本综述重点关注肾固有细胞(包括肾小管上皮细胞、足细胞和内皮细胞)、肾癌细胞和间充质干细胞如何通过自身的表观遗传改变影响巨噬细胞的功能和极化状态,以及巨噬细胞自身的表观遗传调控如何响应肾脏损伤,从而参与肾脏炎症、纤维化和修复。此外,针对这些表观遗传相互作用机制的治疗研究发现,应用组蛋白去乙酰化酶抑制剂、组蛋白甲基转移酶抑制剂、各种纳米材料以及针对非编码RNA的锁核酸对多种肾脏疾病的治疗具有积极作用。本综述总结了这些表观遗传调控机制和治疗方法的最新研究进展,为进一步阐明肾脏疾病的发病机制和开发新的治疗策略提供了理论基础。